Billings Clinic
Especially For:

Clinical Trials

Title   GI Unresectable Hepatocelluar Carcinoma
Description   Phase III Randomized Trial of Chemoembolization with or without Sorafenib in Unresectable Hepatocelluar Carcinoma (HCC) in Patients with or without Vascular Invasion
IRB Number   CTSU E1208
Category   Gastrointestinal
Inclusion/Notes   Please contact Tricia Montgomery, RN for additional inclusion/exclusion criteria.
Status   Active
Start Date   12/11/2009
Principal Investigator (PI)   Roger Santala, MD
Contact Name   Liane Bates RN
Contact Email   lbates@billingsclinic.org
Phone   (406) 435-7481
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.